Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling

Current Osteoporosis Reports

Volumn 8, Issue 2, 2010, Pages 68-76

  Hankenson, Kurt D ^a   Sweetwyne, Mariya T ^a   Shitaye, Hailu ^a   Posey, Karen L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone regeneration; Osteoblast; R spondins; Thrombospondins

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; REGULATOR PROTEIN; ROOF PLATE SPECIFIC SPONDIN; ROOF PLATE SPECIFIC SPONDIN 1; ROOF PLATE SPECIFIC SPONDIN 2; ROOF PLATE SPECIFIC SPONDIN 3; ROOF PLATE SPECIFIC SPONDIN 4; SCLEROPROTEIN; SECRETORY PROTEIN; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; THROMBOSPONDIN 3; THROMBOSPONDIN 4; UNCLASSIFIED DRUG; RSPO4 PROTEIN, HUMAN;

ACHONDROPLASIA; BONE AGE; BONE GROWTH; BONE MASS; BONE REMODELING; BONE STRUCTURE; CELL ACTIVITY; CELL DIFFERENTIATION; CRANIOFACIAL MALFORMATION; DISEASE EXACERBATION; FRACTURE HEALING; FUNCTIONAL DISEASE; GROWTH PLATE; HUMAN; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OVARIECTOMY; PERINATAL PERIOD; PHENOTYPIC VARIATION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETON MALFORMATION; WEIGHT BEARING; ANIMAL; BONE; BONE REGENERATION; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE REGENERATION; BONE REMODELING; HUMANS; OSTEOBLASTS; THROMBOSPONDINS;

EID: 77955984390     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-010-0017-0     Document Type: Review

References (56)

1. Alford AI, Hankenson KD: Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 206, 38:749-757.
2. Bornstein P: Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001, 107:929-934.
3. Lawler J, Duquette M, Urry L, et al.: The evolution of thethrombospondin gene family. J Mol Evol 1993, 36:509-516.
4. Bornstein P, Sage EH: Thrombospondins. Methods Enzymol 1994, 245:62-85.
5. Adams JC: Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 2001, 17:25-51.
6. Bornstein P, Armstrong LC, Hankenson KD, et al.: Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 2000, 19:557-568.
7. Lawler J: The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 2000, 12:634-640.
8. Tucker RP: The thrombospondin type 1 repeat superfamily. Int J Biochem Cell Biol 2004, 36:969-974.
9. Tan K, Duquette M, Liu JH, et al.: Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol 2002, 159:373-382.
10. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al.: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170.
11. Posey KL, Hecht JT: The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets 2008, 9:869-877.
12. Deere M, Sanford T, Ferguson HL, et al.: Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet 1998, 80:510-513.
13. Kim KA, Zhao J, Andarmani S, et al.: R-Spondin proteins: a novel link to beta-catenin activation. Cell Cycle 2006, 5:23-26.
14. Iruela-Arispe ML, Liska DJ, Sage EH, et al.: Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn 1993, 197:40-56.
15. Kyriakides TR, Zhu YH, Yang Z, et al.: The distribution of the matricellular protein, thrombospondin 2, in tissues of embryonic and adult mice. J Histochem Cytochem 1998, 46:1007-1015.
16. Taylor DK, Meganck JA, Terkhorn S, et al.: Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 2009, 24:1043-1054. This study shows that the absence of TSP2 results in alterations in cartilage and bone content in fracture healing.
17. Alford AI, Terkhorn SP, Reddy AB, Hankenson KD: Thrombospondin-2 regulates matrix mineralization in MC3T3- E1 pre-osteoblasts. Bone 2010, 46:464-471. This study shows that TSP2 regulates osteoblastogenesis independent of effects on proliferation.
18. Delany A, Hankenson K: Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 2009, 3:227-238.
19. Riddle R, Khatri R, Schipani E, et al.: Role of hypoxia-inducible factor-1α in angiogenic-osteogenic coupling. J Mol Med 2009, 87:583-590.
20. Meng H, Zhang X, Hankenson KD, et al.: Thrombospondin2 potentiates notch3/jagged1 signaling. J Biol Chem 2009, 284: 7866-7874.
21. Engin F, Lee B: NOTCHing the bone: insights into multifunctionality. Bone 2010, 46:274-280.
22. Akemichi U, Yoshihiro M, Keiko M, et al.: Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization. J Cell Physiol 2006, 209:322-332.
23. Dalla-Torre C, Yoshimoto M, Lee CH, et al.: Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma. BMC Cancer 2006, 6:237.
24. Hankenson KD, Hormuzdi SG, Meganck JA, et al.: Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral head. Mol Cell Biol 2005, 25:5599-5606.
25. Posey KL, Hankenson K, Veerisetty AC, et al.: Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. Am J Pathol 2008, 172:1664-1674. This study showed significant defects in growth cartilage in compound TSP1/ 3/5 knockout mice.
26. Fang C, Carlson CS, Leslie MP, et al.: Molecular cloning, sequencing, and tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP). J Orthop Res 2000, 18:593-603.
27. Posey KL, Davies S, Bales ES, et al.: In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity. Matrix Biol 2005, 24:539-549.
28. Urakami T, Manki A, Inoue T, et al.: Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis. J. Rheumatol 2006, 33:996-1000.
29. Koelling S, Clauditz TS, Kaste M, et al.: Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res Ther 2006, 8:R56.
30. Mann HH, Ozbek S, Engel J, et al.: Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 2004, 279:25294-25298.
31. Hecht JT, Nelson LD, Crowder E, et al.: Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 1995, 10:325-329.
32. Horton WA, Hecht JT: The chondrodysplasias. In Connective Tissue and Its Heritable Disorders. Molecular, Genetic and Medical Aspects, edn 2. New York: Wiley-Liss; 2001:614-675.
33. Hecht JT, Montufar-Solis D, Decker G, et al.: Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol 1998, 17:625-633.
34. Posey KL, Hayes E, Haynes R, et al.: Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol 2004, 36:1005-1012.
35. Merritt TM, Bick R, Poindexter BJ, et al.: Unique matrix structurein the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes. Am J Pathol 2007, 170:293-300
36. Svensson L, Aszodi A, Heinegard D, et al.: Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol Cell Biol 2002, 22:4366-4371.
37. Posey KL, Veerisetty AC, Liu P, et al.: An inducible cartilage oligomeric matrix protein mouse model recapitulates humanpseudoachondroplasia phenotype. Am J Pathol 2009, 175:1555-1563. This seminal study shows that a mouse model of a TSP5 mutation recapitulates the human PSACH condition.
38. Chen FH, Herndon ME, Patel N, et al.: Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem 2007, 282:24591-24598.
39. Kipnes J, Carlberg AL, Loredo GA, et al.: Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage 2003, 11:442-454.
40. Xu K, Zhang Y, Ilalov K, et al.: Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. J Biol Chem 2007, 282:11347-11355.
41. Chen FH, Thomas AO, Hecht JT, et al.: Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 2005, 280:32655-32661.
42. Holden P, Meadows RS, Chapman KL, et al.: Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 2001, 276:6046-6055.
43. Thur J, Rosenberg K, Nitsche DP, et al.: Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 2001, 276:6083-6092.
44. Halasz K, Kassner A, Morgelin M, et al.: COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007, 282:31166-31173.
45. Hecht JT, Hayes E, Haynes R, et al.: COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 2005, 23:525-533.
46. Kamata T, Katsube K, Michikawa M, et al.: R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants. Biochim Biophys Acta 2004, 1676:51-62.
47. Kim KA, Wagle M, Tran K, et al.: R-spondin family members egulate the Wnt pathway by a common mechanism. Mol Biol ell 2008, 19:2588-2596.
48. Bell SM, Schreiner CM, Wert SE, et al.: R-spondin 2 is required or normal laryngeal-tracheal, lung and limb morphogenesis. evelopment 2008, 135:1049-1058.
49. Nam JS, Turcotte TJ, Yoon JK: Dynamic expression of R-spondin amily genes in mouse development. Gene Expr Patterns 2007, :306-312.
50. Chen Y, Alman BA: Wnt pathway, an essential role in bone egeneration. J Cell Biochem 2009, 106:353-362.
51. Aoki M, Kiyonari H, Nakamura H, et al.: R-spondin2 expression in he apical ectodermal ridge is essential for outgrowth and patterning n mouse limb development. Dev Growth Differ 2008, 50:85-95.
52. Nam JS, Park E, Turcotte TJ, et al.: Mouse R-spondin2 is required or apical ectodermal ridge maintenance in the hindlimb. Dev Biol 2007, 311:124-135.
53. Yamada W, Nagao K, Horikoshi K, et al.: Craniofacial malformation n R-spondin2 knockout mice. Biochem Biophys ResCommun 2009, 381:453-458.
54. Blaydon DC, Ishii Y, O'Toole EA, et al.: The gene encoding Rspondin (RSPO4), a secreted protein implicated in Wnt signaling, s mutated in inherited anonychia. Nat Genet 2006, 38:1245-1247.
55. Kriedman MS, Oyserman SM, Hankenson KD: Wnt11 promotes steoblast maturation and mineralization through R-spondin 2. J iol Chem 2009, 284:14117-14125.
56. Lu W, Kim KA, Liu J, et al.: R-spondin1 synergizes withWnt3A ininducing osteoblast differentiation and osteoprotegerin expression. EBS Lett 2008, 582:643-650. This study shows that R-spondin-2 is regulator of BMP-induced osteoblast differentiation.